Logo del repository
  1. Home
 
Opzioni

The paradox of pulmonary arterial hypertension in Italy in the COVID-19 era: is risk of disease progression around the corner?

Roberto Badagliacca
•
Silvia Papa
•
Michele D'Alto
altro
Paola Confalonieri
2022
  • journal article

Periodico
EUROPEAN RESPIRATORY JOURNAL
Abstract
Objective: The coronavirus disease 2019 (COVID-19) outbreak has led to significant restrictions on routine medical care. We conducted a multicentre nationwide survey of patients with pulmonary arterial hypertension (PAH) to determine the consequences of governance measures on PAH management and risk of poor outcome in patients with COVID-19. Materials and methods: The present study, which included 25 Italian centres, considered demographic data, the number of in-person visits, 6-min walk and echocardiographic test results, brain natriuretic peptide/N-terminal pro-brain natriuretic peptide test results, World Health Organization functional class assessment, presence of elective and non-elective hospitalisation, need for treatment escalation/initiation, newly diagnosed PAH, incidence of COVID-19 and mortality rates. Data were collected, double-checked and tracked by institutional records between March 1 and May 1, 2020, to coincide with the first peak of COVID-19 and compared with the same time period in 2019. Results: Among 1922 PAH patients, the incidences of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and COVID-19 were 1.0% and 0.46%, respectively, with the latter comparable to that in the overall Italian population (0.34%) but associated with 100% mortality. Less systematic activities were converted into more effective remote interfacing between clinicians and PAH patients, resulting in lower rates of hospitalisation (1.2% versus 1.9%) and related death (0.3% versus 0.5%) compared with 2019 (p<0.001). A high level of attention is needed to avoid the potential risk of disease progression related to less aggressive escalation of treatment and the reduction in new PAH diagnoses compared with 2019. Conclusion: A cohesive partnership between healthcare providers and regional public health officials is needed to prioritise PAH patients for remote monitoring by dedicated tools.
DOI
10.1183/13993003.02276-2021
WOS
WOS:000882608600009
Archivio
http://hdl.handle.net/11368/3015168
info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85132517429
https://erj.ersjournals.com/content/60/4/2102276.long
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9535117/
Diritti
open access
license:creative commons
license:creative commons
license uri:http://creativecommons.org/licenses/by-nc/4.0/
license uri:http://creativecommons.org/licenses/by-nc/4.0/
FVG url
https://arts.units.it/bitstream/11368/3015168/1/ERJ Badagliacca 2022 earlyview.pdf
Soggetti
  • pulmonary arterial hy...

  • COVID-19

  • SARS-CoV-2

  • infection

  • mortality

  • hospitalization

google-scholar
Get Involved!
  • Source Code
  • Documentation
  • Slack Channel
Make it your own

DSpace-CRIS can be extensively configured to meet your needs. Decide which information need to be collected and available with fine-grained security. Start updating the theme to match your nstitution's web identity.

Need professional help?

The original creators of DSpace-CRIS at 4Science can take your project to the next level, get in touch!

Realizzato con Software DSpace-CRIS - Estensione mantenuta e ottimizzata da 4Science

  • Impostazioni dei cookie
  • Informativa sulla privacy
  • Accordo con l'utente finale
  • Invia il tuo Feedback